What is the primary indication for methylphenidate?

Methylphenidate is primarily indicated for the treatment of attention-deficit hyperactivity disorder (ADHD). This stimulant medication works by increasing the levels of certain neurotransmitters in the brain, particularly dopamine and norepinephrine, which play crucial roles in attention and impulse control. By enhancing these neurotransmitter levels, methylphenidate helps improve focus, reduce hyperactivity, and control impulsive behavior, all of which are key characteristics of ADHD.

The medication can also be used in certain situations to treat narcolepsy, but its main use remains in managing ADHD in children and adults. It is typically part of a comprehensive treatment plan that may also include behavioral therapy and counseling. Understanding this primary indication helps clarify how methylphenidate supports individuals who struggle with the symptoms of ADHD, promoting better academic performance, social interactions, and overall quality of life.